Home » Topics » Medical technology » Diagnostics

Diagnostics
RSS

Neoprobe to develop product for intraoperative detection of neuroblastoma

Dec. 16, 1998

MAA for AcuTect temporarily withdrawn pending submission of additional information

Dec. 15, 1998

DuPont files NDA for its multiapplication ultrasound contrast agent

Dec. 11, 1998

Nycomed Amersham files for approval of novel PD diagnostic

Dec. 11, 1998

New imaging agent using AnorMED technology begins phase III trials

Dec. 10, 1998

Company Profile: Advanced Magnetics

Dec. 8, 1998

Bracco announces approval and launch of second-generation MRI contrast agent

Dec. 4, 1998

Second-generation PD diagnostic enters preclinical development at BLSI

Dec. 3, 1998

Cytogen submits NDS for ProstaScint for approval in Canada and highlights new clinical data

Dec. 3, 1998

Genzyme General receives FDA approval for Thyrogen

Dec. 3, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...